John Neppl - Bunge CFO, Executive Vice President
President
Mr. John W. Neppl is appointed as Chief Financial Officer, Executive Vice President of the Company., effective May 29, 2019. Mr. Neppl joins the Company from Green Plains Inc., where he has served as Chief Financial Officer since 2017. Green Plains is a diversified commodity processing business with operations related to ethanol production, grain handling and storage, cattle feeding, and commodity marketing and logistics services. Prior to Green Plains, Mr. Neppl was a partner at Flatwater Partners from 2016 to 2017. Prior to that, he served as Chief Financial Officer of The Gavilon Group, LLC from 2008 to 2016 and previously held senior financial roles at ConAgra Foods, Inc. since 2019.
| Age | 52 |
| Tenure | 5 years |
| Phone | 314 292 2000 |
| Web | https://www.bunge.com |
Bunge Management Efficiency
The company has return on total asset (ROA) of 6.41 % which means that it generated a profit of $6.41 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 36.06 %, meaning that it generated $36.06 on every $100 dollars invested by stockholders. Bunge's management efficiency ratios could be used to measure how well Bunge manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 7.33 B in total debt with debt to equity ratio (D/E) of 0.91, which is about average as compared to similar companies. Bunge Limited has a current ratio of 1.66, which is within standard range for the sector. Debt can assist Bunge until it has trouble settling it off, either with new capital or with free cash flow. So, Bunge's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bunge Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bunge to invest in growth at high rates of return. When we think about Bunge's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 11 records | PRESIDENT Age | ||
| Martin Berardi | Ternium SA ADR | 66 | |
| KiSeop Jeong | POSCO Holdings | 62 | |
| Cheong Cho | POSCO Holdings | 54 | |
| Thomas Highet | Maiden Holdings | 57 | |
| Bill Horning | Maiden Holdings | N/A | |
| Noah Fields | Maiden Holdings | N/A | |
| Lawrence Metz | Maiden Holdings | 47 | |
| Tom Highet | Maiden Holdings | 54 | |
| Oh Gwon | POSCO Holdings | 66 | |
| Patrick Haveron | Maiden Holdings | 58 | |
| Eun Hwang | POSCO Holdings | 56 | |
Management Performance
| Return On Equity | 36.06 | |||
| Return On Asset | 6.41 |
Bunge Limited Leadership Team
Elected by the shareholders, the Bunge's board of directors comprises two types of representatives: Bunge inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bunge. The board's role is to monitor Bunge's management team and ensure that shareholders' interests are well served. Bunge's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bunge's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Haden Mark, IR Contact Officer | ||
| Jay Winship, Independent Director | ||
| Gordon Hardie, Managing Director of Food and Ingredients | ||
| Paul WaysRuart, Independent Director | ||
| Tommy Jensen, CEO, Bunge Europe, Middle East & Africa | ||
| Vinita Bali, Independent Director | ||
| Frank Jimenez, General Counsel, Managing Director - Government Affairs, Secretary | ||
| Christos Dimopoulos, President - Agribusiness | ||
| Bernard Lauraguais, Independent Director | ||
| Brian Thomsen, Managing Director of Bunge Global Agribusiness and CEO of Bunge Product Lines | ||
| Robert Coviello, Executive Vice President and Chief Growth and Strategy Officer | ||
| Andrew Ferrier, Independent Director | ||
| Brian Zachman, President of Global Risk Management | ||
| Gregory Heckman, Independent Director | ||
| Raul Padilla, Managing Director of Sugar and Bioenergy and CEO of Bunge Brazil | ||
| Thomas Boehlert, CFO, Executive Vice President | ||
| Mark Zenuk, Independent Director | ||
| John McGlade, Independent Director | ||
| Mark Haden, IR Contact Officer | ||
| John Neppl, CFO, Executive Vice President | ||
| Deborah Borg, Chief Human Resource Officer | ||
| Patrick Lupo, Non-Executive Chairman of the Board | ||
| David Kabbes, General Counsel, Managing Director - Corporate Affairs | ||
| Andreas Fibig, Director | ||
| Kathleen Hyle, Independent Director | ||
| Pierre Mauger, Chief Development and Performance Management Officer | ||
| Carol Browner, Independent Director | ||
| Michael Goettl, CEO, Bunge Asia | ||
| Erik Fyrwald, Director | ||
| Ernest Bachrach, Independent Director | ||
| William Engels, Independent Director | ||
| Paul Fribourg, Independent Director | ||
| Enrique Humanes, CEO, Bunge Argentina | ||
| Matt Simmons, Controller, Principal Accounting Officer | ||
| Soren Schroder, CEO and Director | ||
| Enrique Boilini, Independent Director | ||
| Todd Bastean, CEO, Bunge North America | ||
| Andrew Burke, CFO and Global Operational Excellence Officer |
Bunge Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Bunge a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 36.06 | |||
| Return On Asset | 6.41 | |||
| Profit Margin | 4.35 % | |||
| Operating Margin | 4.18 % | |||
| Current Valuation | 25.05 B | |||
| Shares Outstanding | 141.09 M | |||
| Shares Owned By Institutions | 44.32 % | |||
| Price To Earning | 8.98 X | |||
| Price To Book | 2.94 X | |||
| Price To Sales | 0.21 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bunge in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bunge's short interest history, or implied volatility extrapolated from Bunge options trading.
Pair Trading with Bunge
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bunge position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bunge will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to ATyr Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ATyr Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ATyr Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling aTyr Pharma to buy it.
The correlation of ATyr Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ATyr Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if aTyr Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ATyr Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Bunge OTC BB Equity
If you are still planning to invest in Bunge Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bunge's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges |